Diagnostics and therapy of chronic stable coronary artery disease: New guidelines of the European Society of Cardiology;Diagnostik und Therapie der chronisch stabilen koronaren Herzkrankheit: Neue Empfehlungen der Europäischen Gesellschaft für Kardiologie

Herz

Volumn 39, Issue 8, 2014, Pages 902-912

  Athanasiadis, A ^a   Sechtem, U ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Coronary artery vasospasm; Coronary vessels; Guidelines; Microvascular dysfunction; Pretest probability

Indexed keywords

ANTIANGINA PECTORIS AGENT; CARDIOTONIC AGENT;

ALGORITHM; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; DRUG INDICATION; FRACTIONAL FLOW RESERVE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INVASIVE PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; SYMPTOMATOLOGY; SYNTAX SCORE; TREATMENT INDICATION; ANGINA, STABLE; CARDIOLOGY; CARDIOVASCULAR SYSTEM EXAMINATION; CHRONIC DISEASE; COMPLICATION; EUROPE; HEART SURGERY; STANDARDS;

ANGINA, STABLE; CARDIAC SURGICAL PROCEDURES; CARDIOLOGY; CARDIOTONIC AGENTS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EUROPE; HUMANS;

EID: 84922071232     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-014-4159-1     Document Type: Article

References (30)

1. Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003
2. Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999–3054
3. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
4. Emond M, Mock MB, Davis KB et al (1994) Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90:2645–2657
5. Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381
6. Genders TS, Steyerberg EW, Alkadhi H et al (2011) A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 32:1316–1330
7. Patel MR, Peterson ED, Dai D et al (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886–895
8. National Institute for Health and Clinical Excellence (NICE) (2010) Chest pain of recent onset (NICE clinical guideline 95). http://www.nice.org.uk/guidance/cg95/resources/guidance-chest-pain-of-recent-onset-pdf
9. Wolk MJ, Bailey SR, Doherty JU et al (2014) ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 63:380–406
10. Meijboom WB, Mieghem CA van, Mollet NR et al (2007) 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J Am Coll Cardiol 50:1469–1475
11. Fihn SD, Gardin JM, Abrams J et al (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60:e44–e164
12. Deutsche Herzstiftung e. V. (Hrsg) (2013) 25. Deutscher Herzbericht 2013. Deutsche Herzstiftung e. V., Frankfurt, S 66–69
13. Lanza GA, Crea F (2010) Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 121:2317–2325
14. Camici PG, Crea F (2007) Coronary microvascular dysfunction. N Engl J Med 356:830–840
15. Shaw LJ, Bugiardini R, Merz CN (2009) Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 54:1561–1575
16. Yilmaz A, Hill S, Schäufele T et al (2010) Exercise-induced spastic coronary artery occlusion at the site of a moderate stenosis: neither Prinzmetal’s angina nor cardiac syndrome X but „Prinzmetal X“. Circulation 122:e570–e574
17. Prinzmetal M, Kennamer R, Merliss R et al (1959) Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 27:375–388
18. Perk J, De Backer G, Gohlke H et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) *Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 33:1635–1701
19. Athanasiadis A, Sechtem U (2014) Medical therapy of coronary artery disease. MMW Fortschr Med 156:31–34
20. European Medicines Agency (2014) Review of Corlentor/Procoralan started. Press release, 08/05/2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/05/news_detail_002099.jsp&mid=WC0b01ac058004d5c1
21. Kosiborod M, Arnold SV, Spertus JA, McGuire DK (2013) Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol 61:2038–2045
22. Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555
23. TIME Investigators (2001) Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 358:951–957
24. Hueb W, Lopes NH, Gersh BJ et al (2007) Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115:1082–1089
25. Erne P, Schoenenberger AW, Burckhardt D et al (2007) Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 297:1985–1991
26. Boden WE, O’Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516
27. Frye RL, August P, Brooks M et al (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360:2503–2515
28. Nishigaki K, Yamazaki T, Kitabatake A et al (2008) Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease: a randomized, comparative, multicenter study. JACC Cardiovasc Interv 1:469–479
29. Bruyne B de, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001
30. Serruys PW, Onuma Y, Garg S et al (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5:50–56